Native GLP-1 Enhancer
& Multi-Pathway Support.
Feiolix® is derived from premium New Zealand Acca sellowiana, standardised to preserve the full bioactive matrix of the fruit.
It supports:
- Endogenous GLP-1 signalling
- Glucose-dependent insulin secretion
- Insulin sensitivity and glucose uptake
- Thermogenic and mitochondrial activation
- Inflammatory regulation
clinically-supported
outcomes.
Feiolix® demonstrates measurable improvements across metabolic markers in human trials:
Reduce Blood Glucose & HbA1c
- 0.86% HbA1c reduction over 12 weeks
- Comparable to metformin-class outcomes
Reduce Blood Triglycerides & Cardiometabolic Risk
- Lower triglycerides, LDL cholesterol, total cholesterol, and systolic blood pressure
Support Healthy Weight Management
- 24% less weight gain in preclinical models
- Increased brown adipose tissue activity
How Feiolix®
Works.
Feiolix®’s multi-pathway metabolic support is delivered through three core bioactives:
Abscisic Acid (ABA)
Enhances insulin secretion and GLP-1 activity.
Ellagitannins > Urolithins
Anti-inflammatory, supports insulin sensitivity.
Xyloglucan Fibre Matrix
Moderates glucose absorption and supports gut-metabolic axis.
Systems-level activity sets Feiolix® apart from single-compound ingredients.
Designed for
Next-Generation Formulations.
Feiolix® supports product development in:
- Blood glucose management
- GLP-1 supportive nutrition
- Weight management
- Women’s metabolic health
- Cardiometabolic health solutions
weight &
metabolic
hero
weight loss
brand, feiolix
could be your
best decision
yet!
Partner with us for formulation concepts, technical documentation, and claim frameworks.
FEIJOA – NZ’S
superfruit.
Feiolix® is derived from premium New Zealand feijoa and processed using Target Bio-Lock™ technology to preserve the fruit’s natural bioactives:
Standardised
abscisic acid,
polyphenols & fibre.
Verified
consistency
& potency.
Scalable
for B2B
production.
